Laser Vein Therapy

Kulkin, Jay M.; Flash, Shayna

doi:10.1016/j.ogc.2010.09.001

Cited by 3 publications

(5 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most physicians obtain satisfactory results through the injection of sclerosing agents using a 27 or 30 G needle, usually a hypertonic glucose solution at 75%. 8,9 There are numerous studies showing that lasers are efficient and safe to treat telangiectases. 5 Although earlier results were poor, 6,7 they continue to improve as new technologies arise.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Comparison of Laser Versus Sclerotherapy in the Treatment of Lower Extremity Telangiectases: A Prospective Study

Munia¹,

Wolosker²,

Munia

et al. 2012

Dermatologic Surgery

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

“…5 Although earlier results were poor, 6,7 they continue to improve as new technologies arise. 8,9 There are numerous studies showing that lasers are efficient and safe to treat telangiectases. [10][11][12] Many studies have analyzed laser or sclerotherapy to treat leg telangiectasia, [13][14][15] but only a few have prospectively compared one with the other.…”

mentioning

confidence: 99%

Comparison of Laser Versus Sclerotherapy in the Treatment of Lower Extremity Telangiectases: A Prospective Study

Munia¹,

Wolosker²,

Munia

et al. 2012

Dermatologic Surgery

View full text Add to dashboard Cite

show abstract

“…Laser therapies are emerging in the treatment of several conditions, including spider veins, vulvovaginal atrophy, macular disorders, and cancers, 101–104 and the first attempts of using laser therapies in the treatment of PD date back to the eighties 105 …”

Section: Other Non‐invasive Methods Of Treatmentmentioning

confidence: 99%

“…Laser therapies are emerging in the treatment of several conditions, including spider veins, vulvovaginal atrophy, macular disorders, and cancers, [101][102][103][104] and the first attempts of using laser therapies in the treatment of PD date back to the eighties. 105 A randomized double-blind pilot investigated whether addition of laser therapy (BTL-6000 HIGH-INTENSITY LASER 12 W) improved outcomes in patients receiving intralesional verapamil in a group of 38 men.…”

Section: Laser Treatmentmentioning

confidence: 99%

Current trends in non‐surgical management of Peyronie's disease—A narrative review

Kozub,

Suleja,

Chłosta

et al. 2023

Andrology

View full text Add to dashboard Cite

Peyronie's disease (PD) is a connective tissue disorder affecting the tunica albuginea. It can cause pain and penile deformation, and its prevalence increases with age. Although surgery is the gold standard for the chronic phase of the disease, there are several conservative treatment methods available, and the optimal management of the acute phase of the disease remains a matter of debate. In this article, we aim to summarize the recent trends in research on the subject of non‐surgical treatment of PD. The search was performed in PubMed, Scopus, and Web of Science databases and included studies in English published between 2012 and 2022 investigating the clinical outcomes of non‐surgical PD management in humans. We have identified 20 distinct conservative treatment strategies. Among the oral therapeutics, only the use of phosphodiesterase type 5 inhibitors is currently recommended for clinical use in patients with concomitant erectile dysfunction. The use of collagenase from Clostridium histolyticum is supported by the best quality evidence in terms of intralesional injections for patients suffering from significant penile curvature; however, interferon alpha‐2b can also be an option in such patients. Among other non‐invasive methods, extracorporeal shockwaves can be useful for pain reduction, and penile traction therapy can lead to a reduction in penile curvature and plaque size. Despite a wide range of non‐surgical methods available for PD treatment, the majority are not supported by sufficient scientific evidence, and the treatment efficacy is underwhelming. Further research on the subject of non‐surgical management of PD is highly warranted.

show abstract

“…Laser treatment of leg veins is difficult because of a wide range in size and depth, a wide variety in flow, and the many different types of leg vein ectasias. An appropriate work-up should be performed before considering treatment options [4, 11–13]. Currently one of the more common treatment options has been sclerotherapy; it is the injection of sclerosing agents into the vessels.…”

Section: Introductionmentioning

confidence: 99%

Treatment of Superficial Cutaneous Vascular Lesions: Experience with the Long-Pulsed 1064 nm Nd:YAG Laser

Özyurt

Çölgeçen

Baykan

et al. 2012

The Scientific World Journal

View full text Add to dashboard Cite

Recent published studies evaluating the long-pulsed 1064 nm Nd:YAG laser for superficial cutaneous vascular lesions have limited subjects and optimal treatment parameters have not been established. To determine the efficacy and safety of the long-pulsed 1064 nm Nd:YAG laser on superficial cutaneus vascular lesions and analyse retrospectively our experience of a 3-year period are the aims of this study. Over the 3-year period, 255 patients were treated [189 female and 66 male; median age 35 (range 7–65) years; Fitzpatrick skin types II-V]. Twenty-six patients with spider angioma, 130 with facial telangiectasia, and 99 with leg telangiectasia were treated. A long-pulsed 1064 nm Nd:YAG laser was used. A test dose was performed at the initial consultation and thereafter patients were reviewed and treated at 4-week intervals for 5 months. Of those patients who completed treatment and followup, 26/26 (100%) of spider angiomas, 125/130 (97%) of facial telangiectasia, and 80/99 (80,8%) of leg telangiectasia markedly improved or cleared. We suggest that the long pulsed Nd:YAG laser is a safe and effective treatment for common superficial cutaneous vascular lesions. However, it is not the first choise to use to treat superficial vessels on the face where depth is not the concern.

show abstract

Laser Vein Therapy

Cited by 3 publications

References 1 publication

Comparison of Laser Versus Sclerotherapy in the Treatment of Lower Extremity Telangiectases: A Prospective Study

Comparison of Laser Versus Sclerotherapy in the Treatment of Lower Extremity Telangiectases: A Prospective Study

Current trends in non‐surgical management of Peyronie's disease—A narrative review

Treatment of Superficial Cutaneous Vascular Lesions: Experience with the Long-Pulsed 1064 nm Nd:YAG Laser

Contact Info

Product

Resources

About